GSK £400m Cambridge

GSK Announces £400m Cambridge R&D Centre Investment

GSK plans a £400m Cambridge R&D centre, closing its Stevenage facility. This strategic shift supports cost-cutting targets and drug pipeline acceleration despite near-term patent expiries.